# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst Christopher Raymond downgrades VectivBio Holding (NASDAQ:VECT) from Overweight to Neutral and lowers t...
SVB Leerink analyst Thomas Smith downgrades VectivBio Holding (NASDAQ:VECT) from Outperform to Market Perform and lowers the...
Credit Suisse analyst Tiago Fauth downgrades VectivBio Holding (NASDAQ:VECT) from Outperform to Neutral and lowers the price...
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) has agreed to acquire VectivBio Holding AG (NASDAQ: VECT) for $17.00 per share in a...
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the com...
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Friday. Here are some big stocks recording gains in t...
VectivBio Holding AG (NASDAQ: VECT) shares are trading higher Monday after GI-focused healthcare company Ironwood Pharmaceutica...